Free Trial
NASDAQ:AARD

Aardvark Therapeutics 5/14/2025 Earnings Report

Aardvark Therapeutics logo
$11.72 +0.12 (+1.03%)
As of 01:01 PM Eastern

Aardvark Therapeutics EPS Results

Actual EPS
-$0.71
Consensus EPS
-$0.70
Beat/Miss
Missed by -$0.01
One Year Ago EPS
N/A

Aardvark Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Aardvark Therapeutics Announcement Details

Quarter
Time
After Market Closes
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Aardvark Therapeutics Earnings Headlines

AARD - Aardvark Therapeutics Inc Chart - Morningstar
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
See More Aardvark Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Aardvark Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Aardvark Therapeutics and other key companies, straight to your email.

About Aardvark Therapeutics

Aardvark Therapeutics (NASDAQ:AARD) operates as a biotechnology company. It engages in the development of a novel small molecule therapeutics for obesity and metabolic diseases. The company was founded by Tien Lee in 2017 and is headquartered in San Diego, CA.

View Aardvark Therapeutics Profile

More Earnings Resources from MarketBeat